"Developing novel treatments for Dormant Cancers - targeting resistance, metastasis, and relapse."
January 4, 2021 The Journal of Clinical Investigation
"DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3"
April 28, 2020 AACR Annual Meeting
Abstract Number: 5161
Validation of drug candidates targeting dormant cancers in live cells as a key for successful translation into the clinics
May 26, 2019 ASCO Annual Meeting
Abstract Number: 14670
Implication of DYRK1B kinase in dormant glioblastoma cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for glioblastoma.
April 2, 2019 AACR Annual Meeting
Abstract Number: 3038
Implications of DYRK1B kinase in ovarian cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for ovarian cancers
January 11, 2016 8th Annual BIOTECH Showcase
Date and Time: January 13th 2016 8AM
Location: The Parc 55 San Francisco Track A